Cargando…

Cardiotoxicity assessment in breast cancer patients: is it straining?( )

Detalles Bibliográficos
Autores principales:	Villarraga, Hector, Herrmann, Joerg
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2022
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9472782/ https://www.ncbi.nlm.nih.gov/pubmed/36117953 http://dx.doi.org/10.1093/ehjopen/oeac020

Ejemplares similares

Two-dimensional speckle tracking echocardiography predicts early subclinical cardiotoxicity associated with anthracycline-trastuzumab chemotherapy in patients with breast cancer
por: Arciniegas Calle, Maria C., et al.
Publicado: (2018)

Detection of Subclinical Trastuzumab-Induced Cardiotoxicity in Patients with Breast Cancer
por: dos Santos, Marília Harumi Higuchi
Publicado: (2013)

Trastuzumab in Female Breast Cancer Patients With Reduced Left Ventricular Ejection Fraction
por: Nowsheen, Somaira, et al.
Publicado: (2018)

Usefulness of Myocardial Deformation Indices in Preventing Cardiotoxicity in Breast Cancer Patients
por: de Melo, Marcelo Dantas Tavares, et al.
Publicado: (2019)

Cancer Therapy Related Cardiotoxicity
por: Abu-Khalaf, Maysa M, et al.
Publicado: (2011)

Cardiotoxicity due to chemotherapy for breast cancer: The dark side of the moon
por: Peruzzi, Mariangela, et al.
Publicado: (2015)

Cardiotoxicity with vascular endothelial growth factor inhibitor therapy
por: Touyz, Rhian M., et al.
Publicado: (2018)

Global longitudinal strain: an early marker for cardiotoxicity in patients treated for breast cancer
por: van der Linde, D., et al.
Publicado: (2022)

Aging, cardiotoxicity, and chemotherapy
por: Bocchi, Edimar Alcides, et al.
Publicado: (2019)

Trastuzumab Cardiotoxicity in Patients with Breast Cancer
por: Freitas, Aguinaldo Figueiredo, et al.
Publicado: (2014)

Two-dimensional strain echocardiography for detection of cardiotoxicity in breast cancer patients undergoing chemotherapy
por: Toufan, Mehrnoush, et al.
Publicado: (2017)

Cardiotoxicity of plants in South Africa
por: Van Der Bijl, Pieter, et al.
Publicado: (2012)

Molecular mechanisms of anthracycline induced cardiotoxicity: Zebrafish come into play
por: Moossavi, Maryam, et al.
Publicado: (2023)

A cardiotoxicity dataset for breast cancer patients
por: Piñeiro-Lamas, Beatriz, et al.
Publicado: (2023)

Cardiotoxicity and cardiovascular disease risk assessment for patients receiving breast cancer treatment
por: Clark, Robyn A., et al.
Publicado: (2017)

5-fluorouracil and cardiotoxicity: a review
por: Sara, Jaskanwal D., et al.
Publicado: (2018)

Cardiotoxicity: precision medicine with imprecise definitions
por: Chung, Robin, et al.
Publicado: (2018)

Cardiotoxicity Associated with Immune Checkpoint Inhibitors
por: Minegishi, Shintaro, et al.
Publicado: (2023)

Cardiotoxicity from chimeric antigen receptor-T cell therapy for advanced malignancies
por: Totzeck, Matthias, et al.
Publicado: (2022)

Cardiotoxicity among socioeconomically marginalized breast cancer patients
por: Lu, Yan, et al.
Publicado: (2022)

Longitudinal automated assessments of myocardial strain from cine MR in cancer patients receiving cardiotoxic chemotherapy
por: Jolly, Marie-Pierre, et al.
Publicado: (2016)

Highlight report: Cardiotoxicity screening
por: Sachinidis, Agapios
Publicado: (2016)

Cardiac dysfunction from cancer and cancer therapy: new pathways for the prevention of late cardiotoxicity
por: Michel, Lars, et al.
Publicado: (2021)

Checkpoint inhibitor induced cardiotoxicity: managing the drawbacks of our newest agents against cancer
por: Brüstle, Karina, et al.
Publicado: (2017)

Biomarkers for Presymptomatic Doxorubicin-Induced Cardiotoxicity in Breast Cancer Patients
por: Todorova, Valentina K., et al.
Publicado: (2016)

Risks of trastuzumab‐related cardiotoxicity in breast cancer patients in Taiwan
por: Chang, Wei‐Ting, et al.
Publicado: (2021)

Racial Disparity in Anthracycline-induced Cardiotoxicity in Breast Cancer Patients
por: Balaji, Swetha, et al.
Publicado: (2023)

Global longitudinal strain at 3 months after therapy can predict late cardiotoxicity in breast cancer
por: Liu, Zhiyue, et al.
Publicado: (2023)

Rationale for setting up a cardio-oncology unit: our experience at Mayo Clinic
por: Barros-Gomes, Sergio, et al.
Publicado: (2016)

Global Longitudinal Strain Accuracy for Cardiotoxicity Prediction in a Cohort of Breast Cancer Patients During Anthracycline and/or Trastuzumab Treatment
por: Gripp, Eliza de Almeida, et al.
Publicado: (2018)

Cardiotoxicity due to targeted anticancer agents: a growing challenge
por: Shah, Chintan P., et al.
Publicado: (2019)

Perspective on the Cardiotoxicity of Third-Generation Targeted EGFRs in the Treatment of NSCLC
por: Ewer, Michael S., et al.
Publicado: (2021)

Boosting autophagy in anti-tumor proteasome inhibition-mediated cardiotoxicity
por: Papanagnou, Eleni-Dimitra, et al.
Publicado: (2023)

Association of Anthracycline With Heart Failure in Patients Treated for Breast Cancer or Lymphoma, 1985-2010
por: Larsen, Carolyn M., et al.
Publicado: (2023)

Assessment of late cardiotoxic effects in patients treated for cancer in childhood
por: Kincl, Vladimír, et al.
Publicado: (2022)

Cardiotoxicity of concomitant radiotherapy and trastuzumab for early breast cancer
por: Marinko, Tanja, et al.
Publicado: (2014)

Nebivolol effect on doxorubicin-induced cardiotoxicity in breast cancer
por: Cochera, Flavia, et al.
Publicado: (2018)

Evaluation of early subclinical cardiotoxicity of chemotherapy in breast cancer
por: Alıcı, Hayri, et al.
Publicado: (2015)

Efficacy of Dexrazoxane in Preventing Anthracycline Cardiotoxicity in Breast Cancer
por: Macedo, Ariane V.S., et al.
Publicado: (2019)

Risks of Aromatase Inhibitor-Related Cardiotoxicity in Patients with Breast Cancer in Asia
por: Chang, Wei-Ting, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_t98hvegq0it9rfv5pdc9r7nmd1